Author： Erik De Clercq
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.63, Iss.24, 2003-01, pp. : 2767-2768
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 63, Iss. 24, 2003-01 ,pp. :
Access to resources
Recommend
By Chen Ray Y Kilby J Michael Saag Michael S
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. :
Sibrafiban: A Viewpoint by Frans J. Van de Werf
Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. :
Exenatide: A Viewpoint by Curtis Triplitt and Ralph A. DeFronzo
By Triplitt Curtis DeFronzo Ralph A.
Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. :
Triflusal: A Viewpoint by José P. De La Cruz
Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. :